BDNF gene: Functional Val66Met polymorphism in mood disorders and schizophrenia

Pharmacogenomics

Volumn 9, Issue 11, 2008, Pages 1589-1593

  Rybakowski, Janusz K ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

brain derived neurotrophic factor; mood disorders; schizophrenia; Val66Met polymorphism

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CLOZAPINE; FLUOXETINE; FLUVOXAMINE; HALOPERIDOL; LITHIUM SALT; MESSENGER RNA; METHIONINE; MILNACIPRAN; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; SEROTONIN TRANSPORTER; VALINE; VALPROIC ACID;

BIPOLAR DISORDER; BRAIN FUNCTION; DEPRESSION; DOWN REGULATION; DRUG ACTIVITY; EMOTION; GENE EXPRESSION; GENE MAPPING; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HETEROZYGOSITY; HIPPOCAMPUS; HOMOZYGOSITY; HUMAN; MAJOR DEPRESSION; MOOD DISORDER; NERVE CELL PLASTICITY; NONHUMAN; PATHOPHYSIOLOGY; PHARMACOGENOMICS; PREFRONTAL CORTEX; PROPHYLAXIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; TARDIVE DYSKINESIA; UPREGULATION; GENETIC POLYMORPHISM; GENETICS;

ANTIPSYCHOTIC AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MOOD DISORDERS; POLYMORPHISM, GENETIC; SCHIZOPHRENIA;

EID: 61549134224     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/14622416.9.11.1589     Document Type: Review

References (50)

1. Squinto SP, Stitt TN, Aldrich TH, et al. TrkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor. Cell 65, 558-568 (1991).
2. Ashe PC, Berry MD, Bouldton AA: Schizophrenia, a neurodegenerative disorder with neurodevelopmental antecedents. Prog. Neuropsychopharmacol. Biol. Psychiatry 25, 691-707 (2001).
3. Yamada K, Mizuno M, Nabeshima T: Role for brain-derived neurotrophic factor in learning and memory. Life Sci. 70, 735-744 (2002). (Pubitemid 34075562)
4. Maisonpierre PC, Belluscio L, Squinto S, et al. Neurotrophin-3: a neurotrophic factor related to NGF and BDNF. Science 247, 1446-1451 (1990). (Pubitemid 20145051)
5. Pruunsild P, Kazantseva A, Aid T, Palm K, Timmusk T: Dissecting the human BDNF locus: Bidirectional transcription, complex splicing, and multiple promoters. Genomics 90, 397-406 (2007). (Pubitemid 47179877)
6. Egan MF, Kojima M, Callicott JH, et al. The BDNF Val66Met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112, 257-269 (2003). (Pubitemid 36144114)
7. Pezawas L, Verchinski BA, Mattay VS, et al. The brain-derived neurotrophic factor Val66Met polymorphism and variation in human cortical morphology. J. Neurosci. 24, 10099-10102 (2004). (Pubitemid 39492034)
8. Gratacos M, Gonzalez JR, Mercader JM, de Cid R, Urretavizcaya M, Estivill X: Brain-derived neurotrophis factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biol. Psychiatry 61, 911-922 (2007). (Pubitemid 46420580)
9. Hashimoto K, Shimizu E, Iyo M: Critical role of brain derived neurotrophic factor in mood disorders. Brain Res. Rev. 45, 104-114 (2004). (Pubitemid 38625738)
10. Angelucci F, Brene S, Mathe AA: BDNF in schizophrenia, depression and corresponding animal models. Mol. Psychiatry. 10, 345-352 (2005). (Pubitemid 40490802)
11. Post RM: Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications. J. Psychiatr. Res. 41, 979-990 (2007).
12. Sklar P, Gabriel SB, McInnis MG, et al. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Mol. Psychiatry. 7, 579-593 (2002).
13. Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy JL: The brain-derived neurotropic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am. J. Hum. Genet. 71, 651-655 (2002). (Pubitemid 34970137)
14. Green EK, Raybould R, Macgregor S, et al. Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder: case-control study of over individuals from the UK. Br. J. Psychiatry 188, 21-25 (2006). (Pubitemid 43021922)
15. Muller DJ, deLuca V, Sicard T, King N, Strauss J, Kennedy JL: Brain-derived neurotrophic factor gene and rapid-cycling bipolar disorders: family based association study. Br. J. Psychiatry 189, 317-323 (2006). (Pubitemid 44606744)
16. Frey BN, Walss-Bass C, Stanley JA, et al. Brain-derived neurotrophic factor Val66Met polymorphism affect prefrontal energy metabolism in bipolar disorder. Neuroreport 18, 1567-1570 (2007). (Pubitemid 47476385)
17. Rybakowski JK, Borkowska A, Czerski PM, Skibinska M, Hauser J: Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients. Bipolar Disord. 5, 468-472 (2003) (Pubitemid 38072252)
18. Rybakowski JK, Borkowska A, Skibinska M, Hauser J: Illness-specific association of Val66Met BDNF polymorphism with performance on Wisconsin Card Sorting Test in bipolar mood disorder. Mol. Psychiatry 11, 122-124 (2006). (Pubitemid 43164612)
19. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM: Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res. 109, 143-148 (2002). (Pubitemid 34258493)
20. Schumacher J, Jamra RA, Becker T, et al. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol. Psychiatry 58, 307-314 (2005). (Pubitemid 41133624)
21. Hwang JP, Tsai SJ, Hong CJ, Yang CH, Lirng JF, Yang YM: The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression. Neurobiol. Aging 27, 1834-1847 (2006).
22. Oswald P, Del-Favero J, Massat I, et al. No implication of brain-derived neurotrophic factor (BDNF) gene in unipolar affective disorder: evidence from Belgian first and replication patient-control studies. Eur. Neuropsychopharmacol. 15, 491-495 (2005). (Pubitemid 41219618)
23. Pezawas L, Meyer-Linderberg A, Goldman AL, et al. Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression. Mol. Psychiatry. 13, 709-716 (2008) (Pubitemid 351861533)
24. Fukumoto T, Morinobu S, Okamoto Y, et al. Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology (Berl). 158, 100-106 (2001). (Pubitemid 32938319)
25. Rybakowski JK, Suwalska A, Skibinska M, et al. Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene. Pharmacopsychiatry 38, 166-170 (2005). (Pubitemid 41059223)
26. Rybakowski JK, Suwalska A, Skibinska M, Dmmitrzk-Weglarz M, Leszczynska-Rodziewicz A, Hauser J: Response to lithium prophylaxis: interaction between serotonin transporter and BDNF genes. Am. J. Med. Genet. 144B, 820-823 (2007). (Pubitemid 47417214)
27. Matsui T, Hashimoto R, Kusumi I, et al. Lithium response and Val66Met polymorphism of the brain-derived neurotrophic factor gene in Japanese patients with bipolar disorder. Psychiatr. Genet. 16, 49-50 (2006). (Pubitemid 44481202)
28. Siuciak JA, Lewis DR, Wiegand SJ, Lindsay RM: Antidepressant-like effects of brain-derived neurotrophic factor (BDNF). Pharmacol. Biochem. Behav. 56, 131-137 (1997). (Pubitemid 27016116)
29. Nibuya M, Morinobu S, Duman RS: Regulation of BDNF and TrkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatment. J. Neurosci. 15, 7539-7547 (1995).
30. Rogoz Z, Skuza G, Legutko B: Repeated treatment with mitrazepine induces brain-derived neurotrophic factor gene expression in rats. J. Physiol. Pharmacol. 56, 661-671 (2005). (Pubitemid 43127561)
31. Shimizu E, Hashimoto K, Okamura N, et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients without or with antidepressants. Biol. Psychiatry 54, 70-75 (2003). (Pubitemid 36776725)
32. Chen B, Dowlatshahi GM, MacQueen GM, Wang JF, Young LT: Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol. Psychiatry 50, 260-265 (2001). (Pubitemid 32778442)
33. Matrisciano F, Bonacorso S, Ricciardi A, et al. Changes in BDNF serum levels in patients with major depression disorder (MDD) after months treatment with sertraline, escitalopram, or venlafaxine. J. Psychiatr. Res. (2008) (Epub ahead of print).
34. Tsai SJ, Cheng CY, Yu YW, Chen TJ, Hong CJ: Association study of a brain-derived neurotrophic factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response. Am. J. Med. Genet. B Neuropsychiatr. Genet. 123, 19-22 (2003). (Pubitemid 37323258)
35. Yoshida K, Higuchi H, Kamata M, et al. The G196A polymorphism of the brainderived neurotrophic factor gene and the antidepressant effect of milnacipram and fluvoxamine. J. Psychopharmacol. 21, 650-656 (2007). (Pubitemid 47472727)
36. Choi MJ, Kang RH, Lim SW, Oh KS, Lee MS: Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder. Brain Res. 1118, 176-182 (2006). (Pubitemid 44633860)
37. Zai G, Mundo E, Strauss J, Wong GWH, Kennedy JL: Brain-derived neurotrophic factor (BDNF) gene not associated with antidepressant-induced mania. Bipolar Disord. 9, 521-525 (2007). (Pubitemid 47202515)
38. Durany N, Michel T, Zochling R, et al. Brain-derived neurotrophic factor and neurotrophin-3 in schizophrenic psychoses. Schizophr. Res. 52, 79-86 (2001). (Pubitemid 32947050)
39. Neves-Pereira M, Cheung JK, Pasdar A, et al. BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol. Psychiatry 10, 208-212 (2005). (Pubitemid 40188515)
40. Rosa A, Cuesta MJ, Fatjo-Vilas M, Peralta V, Zarzuela A, Fananas L: The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with risk for psychosis: evidence from a familybased association study. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141, 135-138 (2006). (Pubitemid 43214787)
41. Numata S, Ueno S, Iga J, et al. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms. Neurosci. Lett. 401, 1-5 (2006).
42. Szeszko PR, Lipsky R, Mentschel C, et al. Brain-derived neurotrophic factor Val66Met polymorphism and volume of the hippocampal formation. Mol. Psychiatry. 10, 631-636 (2005). (Pubitemid 40961733)
43. Hashimoto R, Moriguchi Y, Yamashita F, et al. Dose-dependent effect of the Val66Met polymorphism of the brain-derived neurptrophic factor gene on memory-related hippocampal activity. Neurosci. Res. 81, 360-367 (2008).
44. Rybakowski JK, Borkowska A, Skibinska M, et al. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene. Psychiatry Clin. Neurosci. 60, 70-76 (2006).
45. Ho BC, Andreasen NC, Dawson JD, Wassink TH: Association between brainderived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia. Am. J. Psychiatry 164, 1890-1899 (2007).
46. Bai O, Chlan-Fourney J, Bowen R, Keegan D, Li XM: Expression of brain derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs. J. Neurosci. Res. 71, 127-131 (2003). (Pubitemid 36008409)
47. Park SW, Lee SK, Kim JM, Yoon JS, Kim YH: Effects of quetiapine on the brain-derived neurotrophic factor expression in the hippocampus and neocortex of rats. Neurosci. Lett. 402, 25-29 (2006). (Pubitemid 43766431)
48. Antilla S, Illi A, Kampman O, Mattila KM, Lehtimaki T, Leinonen E: Lack of association between two polymorphism of brain-derived neurotrophic factor and response to typical neuroleptics. J. Neural Transm. 112, 885-890 (2005). (Pubitemid 40869077)
49. Liou YJ, Liao DL, Chen JY, et al. Association analysis of the dopamine D3 receptor gene ser9gly and brain derived neurotrophic factor gene val66met polymorphisms with antipsychotic induced persistent tardive dyskinesia and clinical expression in Chinese schizophrenic patients. Neuromolecular Med. 5, 243-251 (2004).
50. Hong C-J, Yu YW, Lin CH, Tsai SJ: An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients. Neurosci. Lett. 349, 206-208 (2003).